Mitochondrially targeted tamoxifen alleviates markers of obesity and type 2 diabetes mellitus in mice.

Vacurova E, Trnovska J, Svoboda P, Skop V, Novosadova V, Reguera DP, Petrezselyová S, Piavaux B, Endaya B, Spoutil F, Zudova D, Stursa J, Melcova M, Bielcikova Z, Werner L, Prochazka J, Sedlacek R, Huttl M, Hubackova SS, Haluzik M, Neuzil J

Open source

DOI
10.1038/s41467-022-29486-z
Published
2022 Apr 6
Container
Nature communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41467-022-29486-z,
  title = {Mitochondrially targeted tamoxifen alleviates markers of obesity and type 2 diabetes mellitus in mice.},
  author = {Vacurova E and Trnovska J and Svoboda P and Skop V and Novosadova V and Reguera DP and Petrezselyová S and Piavaux B and Endaya B and Spoutil F and Zudova D and Stursa J and Melcova M and Bielcikova Z and Werner L and Prochazka J and Sedlacek R and Huttl M and Hubackova SS and Haluzik M and Neuzil J},
  year = {2022},
  journal = {Nature communications},
  doi = {10.1038/s41467-022-29486-z},
  url = {https://doi.org/10.1038/s41467-022-29486-z}
}

RIS

TY  - JOUR
TI  - Mitochondrially targeted tamoxifen alleviates markers of obesity and type 2 diabetes mellitus in mice.
AU  - Vacurova E
AU  - Trnovska J
AU  - Svoboda P
AU  - Skop V
AU  - Novosadova V
AU  - Reguera DP
AU  - Petrezselyová S
AU  - Piavaux B
AU  - Endaya B
AU  - Spoutil F
AU  - Zudova D
AU  - Stursa J
AU  - Melcova M
AU  - Bielcikova Z
AU  - Werner L
AU  - Prochazka J
AU  - Sedlacek R
AU  - Huttl M
AU  - Hubackova SS
AU  - Haluzik M
AU  - Neuzil J
PY  - 2022
JO  - Nature communications
DO  - 10.1038/s41467-022-29486-z
UR  - https://doi.org/10.1038/s41467-022-29486-z
ER  - 

APA

E, V., J, T., P, S., V, S., V, N., DP, R., S, P., B, P., B, E., F, S., D, Z., J, S., M, M., Z, B., L, W., J, P., R, S., M, H., SS, H., M, H., & J, N. (2022). Mitochondrially targeted tamoxifen alleviates markers of obesity and type 2 diabetes mellitus in mice.. Nature communications. https://doi.org/10.1038/s41467-022-29486-z

Source records